| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $38.7M | — | -6.4% |
| Cost of Revenue | $23.6M | — | -15.2% |
| R&D Expense | $6.1M | — | -25.6% |
| SG&A Expense | $9.6M | — | -43.0% |
| Operating Income | -$5.1M | — | +87.7% |
| Pre-tax Income | -$4.4M | — | +89.0% |
| Income Tax | $40K | — | -63.0% |
| Net Income | -$4.4M | — | +88.9% |
| EPS (Basic) | -$0.02 | — | +90.5% |
| EPS (Diluted) | -$0.02 | — | +90.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $98.8M | -5.5% | -21.3% |
| Accounts Receivable | $36.8M | -22.5% | -26.3% |
| Inventory | $24.4M | -8.5% | -26.5% |
| Current Assets | $168.6M | -10.3% | -26.0% |
| Total Assets | $300.2M | -6.4% | -18.0% |
| Current Liabilities | $42.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.5M | — | +62.7% |
| Capital Expenditures | $30K | — | -98.6% |
| Investing Cash Flow | -$1.1M | — | +68.6% |
| Financing Cash Flow | $393K | — | +126.1% |
| Free Cash Flow | -$4.6M | — | +68.1% |
| -43.7% |
| Total Liabilities | $69.6M | -21.7% | -39.7% |
| Stockholders' Equity | $230.7M | -0.6% | -8.0% |